Prospects of FDI-Driven R&D—A Comparison Between Indian and Foreign Pharmaceutical Firms

J. C. Sharmiladevi ()
Additional contact information
J. C. Sharmiladevi: Symbiosis Centre for Management Studies, Symbiosis International (Deemed University)

A chapter in Achieving $5 Trillion Economy of India, 2022, pp 21-41 from Springer

Abstract: Abstract It is now an acknowledged and well-researched fact that foreign direct investment facilitates and enhances development of underdeveloped and developing economies. Multinational companies have also understood that with FDI, they can do more business than any other form of internationalization. India has proved to be as one of the attractive destinations for research and development (R&D). R&D FDI in India is increasing, but, at the same time, this increase is not matching with core R&D activities. Non-core R&D activates dominate 50% inflow of R&D, as most of these activities get tax concession from the government. R&D FDI is mainly made to take benefits, tax concessions from the government, which dilutes the desired benefits and spillover effects of FDI. An attempt is made in this chapter to check whether the foreign companies are going in tune with Indian companies in creating more R&D. Data is taken from pharmaceuticals companies, where the R&D intensity is very high. R&D and innovative potentials of foreign and Indian companies are compared from their balance sheet data. Results indicate that Indian owned companies are investing more towards R&D, than foreign owned companies, which is a highly encouraging phenomenon considering the current demand for innovation .

Keywords: Research and development; Multinational corporations; Indian companies and foreign direct investment (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:prbchp:978-981-16-7818-9_2

Ordering information: This item can be ordered from
http://www.springer.com/9789811678189

DOI: 10.1007/978-981-16-7818-9_2

Access Statistics for this chapter

More chapters in Springer Proceedings in Business and Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().